The Classification of Malignant Melanoma, its Histological Reporting and Registration: A Revision of the 1972 Sydney Classification

References

• McGovern V J, Mihm M C, Bailey C, et al. The classification of malignant melanoma and its histologic reporting. Cancer 1973; 32: 1446–57
   PubMed Web of Science ®Google Scholar
• Clark WH, Jr. A classification of malignant melanoma in man correlated with histogenesis and biologic behavior. Advances in Biology of the Skin, the Pigmentary System, W Montagna, F Hu. Pergammon Press, Ltd, London 1967; vol. 8.: 621–45
   Google Scholar
• McGovern VJ. The classification of melanoma and its relationship with prognosis. Pathology 1970; 2: 85–98
   PubMed Web of Science ®Google Scholar
• Consensus Conference. Precursors to malignant melanoma. J Am Med Assoc 1984; 251: 1864–6
   PubMed Web of Science ®Google Scholar
• Mihm MC, Jr., Fikpatrick T B, Lane Blown MW, et al. Early detection of primary cutaneous malignant melanoma. A color atlas. N Engl J Med 1973; 289: 989–96
   Web of Science ®Google Scholar
• Cascinelli N, Morabito A, van der Esch EP, et al. Prognosis of Stage 1 melanoma of the skin. Int J Cancer 1980; 26: 733–9
   Google Scholar
• Breslow A. Thickness, cross-sectional area, and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 1970; 172: 902–8
   PubMed Web of Science ®Google Scholar
• Breslow A. Prognosis in cutaneous melanoma: Tumor thickness as a guide to treatment. Pathology Annual, S C Sommers, P P Rosen. Appleton-Century Crofts, New York 1980; vol. 15.: 1–22, Part I
   Google Scholar
• Day C L, Harris T J, Gorstein F, et al. Malignant melanoma: Prognostic significance of “microscopic satellites” in the reticular dermis and subcutaneous fat. Ann Surg 1981; 194: 108–12
   PubMed Web of Science ®Google Scholar
• Prade M, Sancho-Garnier H, Cesarini JP, et al. Difficulties encountered in the application of the Clark classification and Breslow thickness measurement in cutaneous malignant melanoma. Int J Cancer 1980; 26: 159–63
   PubMedGoogle Scholar
• Balch C M, Wilkerson J A, Murad TM, et al. The prognostic significance of ulceration of cutaneous melanoma. Cancer 1980; 45: 3012–7
   PubMed Web of Science ®Google Scholar
• Schmoeckel C, Bockelbrink A, Bockelbrink H, et al. Low- and high-risk malignant melanoma. I. Evaluation of clinical and histological prognosticators in 585 cases. Eur J Cancer Clin Oncol 1983; 19: 227–35
   Google Scholar
• Gromet M A, Epstein W L, Blois MS. The regressing thin malignant melanoma. A distinctive lesion with metastatic potential. Cancer 1978; 42: 2282–92
   PubMed Web of Science ®Google Scholar
• Little J H, Davis NC. Secondary malignant melanoma in lymph nodes: Incidence, time of occurrence and mortality. Aust NZ J Surg 1978; 48: 9–13
   Google Scholar
• Giuliano A E, Cochran A J, Morton DL. Melanoma from unknown primary sites and amelanotic melanoma. Sem Oncol 1982; 9: 442–7
   PubMed Web of Science ®Google Scholar
• Little JH. (1972) Histology and prognosis in cutaneous malignant melanoma. Melanoma and Skin Cancer. Proceedings of the International Cancer Conference, Sydney, 1972. VCN Bligh, Government Printer, Sydney, 107–20
   Google Scholar
• Ainsworth A M, Folberg R, Reed R J, Clark WH, Jr. Melanocytic nevi, melanocytomas, melanocytic dysplasias and uncoinnion forms of melanoma. Human Malignant Melanoma, WH Clark, Jr., L I Goldman, M J Mastrangelo. Grune and Stratton, New York 1979; 167–208
   Google Scholar
• Sagebiel RW. Histopathology of borderline and early malignant melanomas. Am J Surg Pathol 1979; 3: 543–52
   Google Scholar
• Cochran AJ. Histology of borderline and atypical cutaneous malignant melanoma. Malignant Melanoma. Advances of a Decade, R M MacKie. S. Karger. Pigment Cell, Basel 1983; 6: 36–64
   Google Scholar
• Elder D E, Greene M H, Bondi EE, . Acquired melanocytic nevi and melanoma: The dysplastic nevus syndrome. Pathology of Malignant Melanoma, A B Ackerman, et al. Masson Publishing, USA, New York 1981; 185–216
   Google Scholar
• Kamino H, Ackerman AB. Malignant melanoma in situ: The evolution of malignant melanoma within the epidermis. Pathology of Malignant Melanoma, A B Ackerman. Masson Publishing, USA, New York 1981; 59–92
   Google Scholar
• Hamburger A W, Salmon SE. Primary bioassay of human tumor cells. Science 1977; 197: 461–3
   PubMed Web of Science ®Google Scholar
• Cochran A J, Wen D-R, Herschman HR, et al. Detection of S-100 protein as an aid to the classification of melanocytic tumors. Int J Cancer 1982; 30: 295–7
   PubMed Web of Science ®Google Scholar
• Koprowski H, Steplewski Z, Herlyn D, et al. Study of antibodies against human melanoma produced by somatic cell hybrids. Proc Natl Acad Sci USA 1978; 75: 3405–9
   PubMed Web of Science ®Google Scholar
• Burk M W, Saxton R E, Mann BA, et al. Definition of human melanoma-associated cell surface antigens by hybridoma monoclonal antibodies. Surgery 1983; 94: 84–90
   Google Scholar
• Cohen M H, Ketcham A S, Felix EL, et al. Prognostic factors in patients undergoing lymphadenectomy for malignant melanoma. Ann Surg 1977; 186: 635–42
   PubMed Web of Science ®Google Scholar
• Balch C M, Soong S-J, Murad TM, et al. A multifactoral analysis of melanoma. III. Prognostic factors in melanoma patients with lymph node metastases (Stage II). Ann Surg 1981; 193: 377–88
   PubMed Web of Science ®Google Scholar
• Callery C, Cochran A J, Roe DJ, et al. Factors prognostic for survival in patients with malignant melanoma spread to the regional lymph nodes. Ann Surg 1982; 196: 69–75
   PubMed Web of Science ®Google Scholar